Fifth Lane Capital »

Phoenix Biotech Acquisition Class A shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Phoenix Biotech Acquisition Class A (CERO) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Phoenix Biotech Acquisition Class A

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition Class A held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition Class A by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.9k 77k 0.09
2024-06-30 $0 77k 0.00

More positions owned by Fifth Lane Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Investcorp Europe Acquisitio Class A Ord Shs (IVCB)
Southwestern Energy Company
Endeavor Group Hldgs Cl A Com (EDR)
Albertsons Cos Common Stock (ACI)
Envestnet (ENV)
SITE Centers Corp
Smartsheet Com Cl A (SMAR)
Monolithic Power Systems (MPWR)
Sbny 5.0 31 Dec 2049 A - P Common Shares (SBNYL)
Select Sector Spdr Tr Indl (XLI)
Ansys (ANSS)
Applovin Corp Com Cl A (APP)
Loar Holdings Com Shs (LOAR)
Ultragenyx Pharmaceutical (RARE)

View all positions for Fifth Lane Capital

Top funds holding Phoenix Biotech Acquisition Class A

Arch Venture Corp
Arena Investors
Geode Capital Management
Honkamp Krueger Financial Services
Hrt Financial
Fifth Lane Capital
Jane Street
FNY Investment Advisers
Two Sigma Investments
CI Private Wealth
Birchview Capital
Jump Financial
Advisor Group Holdings
Pineridge Advisors
Bank of America Corporation

View all funds holding Phoenix Biotech Acquisition Class A